ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Example of how patients are managed based on risk estimates (using a common low-grade screening abnormality, HPV-positive ASC-US)

Example of how patients are managed based on risk estimates (using a common low-grade screening abnormality, HPV-positive ASC-US)
The initial screening result would lead to colposcopy (immediate risk 4.2%). Colposcopy of less than CIN 2 has a 5-year risk of 3.2% (1-year return). At the 1-year return visit, a second HPV-positive ASC-US result has an immediate risk of 3.1% (1-year return). If the patient has a repeat abnormal screen at the next follow-up, colposcopy is recommended. If the HPV-based test is negative, return in 3 years is recommended. NA, not applicable because stable risk estimates are not available.
HPV: human papillomavirus; ASC-US: atypical squamous cells of undetermined significance; CIN: cervical intraepithelial neoplasia; NILM: negative for intraepithelial lesion or malignancy; NA: not applicable because stable risk estimates are not available.
From: Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020; 24:102. DOI: 10.1097/LGT.0000000000000525. Copyright © 2020 the American Society for Colposcopy and Cervical Pathology. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.
Graphic 127898 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟